塞德斯醫療 CLDX 深 滬
已收盤 07-02 16:00:00 美东时间
38.37
+1.590
+4.32%
華盛通- 最 高38.425
- 今 開36.95
- 成交量 87.68万股
- 最 低 36.175
- 昨 收 36.78
- 總市值 30.12亿
- 52周最高 39.1594
- 市盈率 靜 --
- 換手率 1.12%
- 52周最低 19.7225
- 委 比 -9.43%
- 總股本 7849.21万
- 歷史最高 582.60
- 量 比 0.41
- 振 幅 6.12%
- 歷史最低 1.50
- 每 手 1
- 風險率 3.87%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Celldex Therapeutics Inc（CLDX）股价在2027年潜在获批前是否具备增长潜力
赛尔迭克斯治疗公司（纳斯达克代码：CLDX）入选分析师推荐的10只最优生物科技买入股榜单。 关键机构动作与数据： 6月10日瑞银将CLDX目标价从38美元上调至...
06-30 21:52
Celldex Therapeutics shareholders approve 3,400,000-share increase to 2021 equity plan at annual meeting
Celldex Therapeutics shareholders approve 3,400,000-share increase to 2021 equity plan at annual meeting Celldex held its annual shareholder meeting on June 25, 2026. Shareholders ratified PricewaterhouseCoopers as independent registered public accounting firm for the year ending Dec. 31, 2026. Inve
06-26 20:47
美股大行评级 | 大摩再上调希捷科技和西部数据目标价；多家大行首予Lincoln买入评级
今日重点评级关注：HC Wainwright & Co.：维持Elicio Therapeutics"买入"评级，目标价从17美元升至23美元；Leerink Partners：维持SAB Biotherapeutics"跑赢大市"评级，目标价从7美元升至12美元
06-16 11:34
美股大行评级 | 高盛上调美光科技目标价从400美元升至900美元；斯马克、Cloudflare获多家公司上调目标价
今日重点评级关注：Ascendiant Capital：维持NextTrip"买入"评级，目标价从7美元升至7.5美元；Maxim Group：维持Zevra Therapeutics"买入"评级，目标价从25美元升至35美元
06-11 09:55
UBS Maintains Buy on Celldex Therapeutics, Raises Price Target to $45
UBS analyst David Dai maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $38 to $45.
06-11 01:24
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
Celldex will present three studies at the EAACI Congress in Istanbul, including barzolvolimab's long-term results in chronic spontaneous urticaria and cold urticaria, and CDX-622's Phase 1 data targeting mast cell pathways. Barzolvolimab, a monoclonal antibody, inhibits mast cell activity via KIT receptor targeting, showing potential as a first-in-class treatment for chronic urticarias. CDX-622, a bispecific antibody, neutralizes TSLP and SCF to ...
06-10 20:01
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Co-Diagnostics (NASDAQ:CODX) shares rose 20.8% to $2.38 during Tuesday...
05-20 05:06
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Barclays Maintains Overweight on Celldex Therapeutics, Raises Price Target to $48
Barclays analyst Etzer Darout maintains Celldex Therapeutics (NASDAQ:CLDX) with a Overweight and raises the price target from $45 to $48.
05-08 22:42
